Ambulatory surgery centers (ASCs) offer opportunities to improve efficiencies and outcomes--can your products play a role?
Business - Industry Insight
In a new report, Decision Resources Group (DRG) experts have highlighted four medtech innovations that they see tearing up the script.
The company is bracing for a $25 million revenue hit after FDA ordered two of its mesh products off the market, but a bigger concern may be lying in wait.
Selling to a large company can be an attractive option, but medtech startups must go into the sales process prepared. Here's what you need to know to sell your company at top dollar.
The shift toward value-based care has changed the radiology game for both the providers and the companies making new imaging technology.
Manufacturers should work to fill gaps in their portfolios to master disease management rather than focusing solely on one particular device category.
CEO John Onopchenko said the company is shifting from a defensive position to an offensive position and expects to return to growth in the second half of the year.
The diabetes devices market is more competitive than ever before. Here's what we expect to see this year from the leading players in the space.
These tweets about medical devices and health conditions are proof that sometimes laughter really is the best medicine.
Hackers have already demanded ransom for removing sensitive patient data. Could your product foil future attacks?
NuVasive has been in the news this week after it was reported that Smith & Nephew was interested in acquiring the company for more than $3 billion. Neither company has officially commented on the rumored deal.
As Zimmer Biomet prepares to enter a surging robotics market, CEO Bryan Hanson said the company wants to make sure the company does it right.